Accueil
Détail de l'auteur
Documents disponibles écrits par cet auteur
Ajouter le résultat dans votre panier Faire une suggestion Affiner la rechercheArticle : Périodique
L. PLATT ; J. REED ; S. MINOZZI ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; M. HICKMAN |This is the protocol for a review and there is no abstract. The objectives are as follows: 1. To assess the impact of needle/syringe programmes with and without opiate substitution therapy (OST) on the incidence of HCV infection among people w[...]Article : Périodique
V. HOPE ; J. KIMBER ; P. VICKERMAN ; M. HICKMAN ; F. NCUBE |BACKGROUND: Injection site infections among injecting drug users (IDUs) have been associated with serious morbidity and health service costs in North America. This study explores the frequency, factors and costs associated with injection site in[...]Article : Périodique
V. HOPE ; J. V. PARRY ; A. MARONGUI ; F. NCUBE |Around 80% of hepatitis C virus (HCV) infections in England are among injecting drug users (IDUs). The HCV Action Plan launched in 2004 includes targets to reduce HCV prevalence in recent initiates (those starting injecting in the preceding 3 ye[...]Article : Périodique
D. HEDRICH ; E. KALAMARA ; O. SFETCU ; A. PHARRIS ; A. NOOR ; L. WIESSING ; V. HOPE ; M. J. VAN DE LAAR |In most European Union (EU)/European Economic Area (EEA) countries, between 2010 and 2012, reports of new human immunodeficiency virus (HIV) diagnoses among people who inject drugs have been stable or declining. HIV outbreaks in Greece and Roman[...]Article : Périodique
M. HICKMAN ; HIGGINS V. ; V. HOPE ; M. A. BELLIS ; K. TILLING ; A. WALKER ; J. HENRY |Study objective: To estimate the prevalence of injecting drug use (IDU) in three cities in England and to measure the coverage of key public health indicators. Design: Capture-recapture techniques with covariate effects. Setting: Liverpool, Brig[...]Article : Périodique
G. J. MACARTHUR ; E. VAN VELZEN ; N. E. PALMATEER ; J. KIMBER ; A. PHARRIS ; V. HOPE ; A. TAYLOR ; K. ROY ; E. ASPINALL ; D. GOLDBERG ; T. RHODES ; D. HEDRICH ; M. SALMINEN ; M. HICKMAN ; S. J. HUTCHINSON |BACKGROUND: Injecting drug use is a major risk factor for the acquisition and transmission of HIV and Hepatitis C virus (HCV). Prevention of these infections among people who inject drugs (PWID) is critical to reduce ongoing transmission, morbid[...]Article : Périodique
V. HOPE ; A. JEANNIN ; B. SPENCER ; J. P. GERVASONI ; M. J. VAN DE LAAR ; F. DUBOIS-ARBER ; ECDC HIV and STI Behavioural Surveillance Mapping Group |The systematic collection of behavioural information is an important component of second-generation HIV surveillance. The extent of behavioural surveillance among injecting drug users (IDUs) in Europe was examined using data collected through a [...]Article : Périodique
F. DUBOIS-ARBER ; A. JEANNIN ; B. SPENCER ; J. P. GERVASONI ; B. GRAZ ; J. ELFORD ; V. HOPE ; F. LERT ; H. WARD ; M. HAOUR-KNIPE ; N. LOW ; M. J. VAN DE LAAR |BACKGROUND: Used in conjunction with biological surveillance, behavioural surveillance provides data allowing for a more precise definition of HIV/STI prevention strategies. In 2008, mapping of behavioural surveillance in EU/EFTA countries was p[...]Article : Périodique
L. PLATT ; S. MINOZZI ; J. REED ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; J. BRUNEAU ; M. HICKMAN |Aims: To estimate the effects of needle and syringe programmes (NSP) and opioid substitution therapy (OST), alone or in combination, for preventing acquisition of hepatitis C virus (HCV) in people who inject drugs (PWID). Methods: Systematic re[...]Article : Périodique
L. PLATT ; S. MINOZZI ; J. REED ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; J. BRUNEAU ; M. HICKMAN |Review question: We examine research on the effect of needle syringe programmes (NSP) and opioid substitution treatment (OST) in reducing the risk of becoming infected with the hepatitis C virus. Background: There are around 114.9 million peopl[...]Article : Périodique
H. L. MILLS ; C. COLIJN ; P. VICKERMAN ; D. LESLIE ; V. HOPE ; M. HICKMAN |Background: A 2006 respondent driven sampling (RDS) survey of injecting drug users (IDUs) in Bristol, UK, estimated 40 per 100 person years HCV incidence but in 2009 another RDS survey estimated only 10 per 100 person years incidence amongst the[...]Périodique
C. FITCH ; T. RHODES ; V. HOPE ; G. V. STIMSON ; A. RENTON | 2002FRANÇAIS : La méthode d"`évaluation rapide" offre la possibilité de générer des informations importantes pour la santé publique qui peuvent être utilisées parallèlement aux systèmes de suivi et de surveillance et aux autres mécanismes disponibl[...]Article : Périodique
C. EDMUNDSON ; E. HEINSBROEK ; R. GLASS ; V. HOPE ; H. MOHAMMED ; M. WHITE ; M. DESAI |Background: Sexualised drug use (SDU) refers to the use of drugs in a sexual context. This includes 'Chemsex'- the use of drugs (specifically crystal methamphetamine, GHB/GBL and mephedrone) before or during planned sexual activity to sustain, e[...]Rapport
The report suggests that homeless people who inject drugs are more likely to share needles and syringes: One in four IDUs who reported being homeless said that they had shared needles and syringes in the last month, compared with one in six who [...]Article : Périodique
C. O'HALLORAN ; K. CULLEN ; J. NJOROGE ; L. JESSOP ; J. SMITH ; V. HOPE ; F. NCUBE |Background: Overdose is a major cause of death among PWID, and for opioid overdoses naloxone administration can reduce harm. However, globally there is limited national level data on the extent of non-fatal overdose and naloxone uptake. The firs[...]Nouveauté
